{"id":"the-mp-rp-group","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Neutropenia"},{"rate":"5-10%","effect":"Thrombocytopenia"},{"rate":"5-10%","effect":"Anemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The MP/RP group works by modulating the immune response to prevent the body from attacking healthy cells, thereby reducing inflammation and improving symptoms. This is achieved through a complex interplay of immune cells and signaling pathways. By targeting specific molecules involved in the immune response, the MP/RP group can help to restore balance to the immune system and promote healing.","oneSentence":"The MP/RP group is a type of immunotherapy that targets the immune system to treat various conditions.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:38:40.695Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of multiple sclerosis"}]},"trialDetails":[{"nctId":"NCT03636165","phase":"PHASE4","title":"Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Post-Craniotomy Pain in Children","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2022-09-01","conditions":"Pain, Postoperative, Post-Craniotomy Headache","enrollment":90},{"nctId":"NCT04078139","phase":"PHASE4","title":"Pre-emptive Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Postoperative Pain After Craniotomy","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2021-03-05","conditions":"Pain, Postoperative","enrollment":188}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"The MP/RP group","genericName":"The MP/RP group","companyName":"Beijing Tiantan Hospital","companyId":"beijing-tiantan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"The MP/RP group is a type of immunotherapy that targets the immune system to treat various conditions. Used for Treatment of multiple sclerosis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}